Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen to Sell Chromatography Business to Pall in $32M Deal

NEW YORK , Oct. 28 (GenomeWeb News) - Ciphergen Biosystems will sell its BioSepra process chromatography business to Pall Corporation for $32 million, and the companies will enter into a collaboration the firms said today.


New York-based Pall will establish process proteomics service centers to offer protein purification using Ciphergen's BioSepra's chromatography products and ProteinChip technology.


Ciphergen will retain certain limited rights to access BioSepra's chromatography sorbent technology for use in research and diagnostic markets, the company said.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.